Pathology

Marina Ivanovic, MD

Portrait

Director of Thoaracic Pathology-Holden Comprehensive Cancer Center
Clinical Associate Professor of Pathology
Clinical Associate Professor of Pathology  - Anatomic Pathology

Contact Information

Primary Office: 5243 Roy Carver Pavilion
Iowa City, IA 52242
Primary Office Phone: 319-353-6861

Email: marina-ivanovic@uiowa.edu

Education

RN, Dubrovnik Secondary School and School of Nursing, Dubrovnik Croatia
MD, University of Zagreb School of Medicine, Zagreb, Croatia

Transitional Year, University Hospital “Merkur”, Zagreb, Croatia
Residency, Anatomic Pathology, Boston University Medical Center
Residency, Clinical Pathology, Boston University Medical Center
Fellowship, Cytopathology, Boston University Medical Center
Fellowship, Surgical Pathology, University of Chicago Medical Center

Licensure and Certifications

State of Illinois Medical License, Illinois Board of Medicine
State of Massachusetts Medical License, Massachusetts Board of Medicine
Anatomic and Clinical Pathology, American Board of Pathology
Cytopathology, American Board of Cytopathology
Cytopathology, Interenation Academy of Cytopathology Board

Research Summary

Interests: Diagnostic surgical pathology and cytopathology.

Center, Program and Institute Affiliations

Holden Comprehensive Cancer Center

All Publications

Ivanovic M.  Distinguish the Lineage of the Sex Cord-stromal Cells in Gonadoblastoma.  Pediatric and Developmental Pathology.  2011. 

Ivanovic M.  Resferatrol and its Analogues as chemopreventive and Anticancer Agents in Prostate Cancer: Epigenetic Mechanisms of Action.  Tenth Annual AACR International Conference on Frontiers in Cancer Prevention Research.  2011. 

Ivanovic M.  Sertoli-Leydig Cell Tumors: Just Variants Of Granulosa Cell tumors? - FOXL2, SOX9 and SRY Distinguish The Lineage Of The Sex Cord Derivatives.  100th Annual Meeting of United States and Canadian Academy of Pathology.  2011. 

Ivanovic M.  Sex Cord Tumor With Annular Tubules (SCTAT): A Rare Variant of Granulosa Cell Tumors? FOXL2 and SOX9 Distinguish the Lineage of the Sex Cord Derivatives.  00th Annual Meeting of United States and Canadian Academy of Pathology.  2011. 

Ivanovic M.  Targeting Prostate Cancer Angiogenesis Through Metastasis-Associated Antigen 1 (MTA 1).  Prostate.  2011. 71(3):268-280.

Ivanovic M.  Fine-Needle Aspiration of Hurthle Cell Neoplam.  17st International Congress of Cytology.  2010. 

Ivanovic M.  FOXL2 and SOX9 Distinguish the Origin of the Sex-Cord Cells in Gonadoblastoma.  99th Annual Meeting of United States and Canadian Academy of Pathology.  2010. 

Ivanovic M.  FOXL2-A Novel Marker for Granulosa Cell Tumors.  99th Annual Meeting of United States and Canadian Academy of Pathology.  2010. 

Ivanovic M.  On the Dynamics of Nitrite, Nitrate and Other Biomarkers of Nitric Oxide Production in Inflammatory Bowel disease. Nitric Oxide.  Nitric Oxide.  2010. 22(2):155-167.

Nayar R, Ivanovic M.  The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.  Cancer.  2009 June. 117(3):195-202.
[PubMed]

Zhang S, Ivanovic M, Nemcek A, Defrias D, Lucas E, Nayar R.  Thin core needle biopsy crush preparations in conjunction with fine-needle aspiration for the evaluation of thyroid nodules: a complementary approach.  Cancer.  2008 December. 114(6):512-8.
[PubMed]

Veliceasa D, Ivanovic M, Hoepfner F, Thumbikat P, Volpert O, Smith N.  Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.  The FEBS journal.  2007 December. 274(24):6365-77.
[PubMed]

Ivanovic M.  Evaluation of Biomarkers in Lobular Carcinoma in Situ.  21st European Congress of Pathology,.  2007. 

Ivanovic M.  Evaluation of Nuclear Grade in Lobular Carcinoma in Situ (LCIS) Correlation with Image Cytometry.  21st European Congress of Pathology,.  2007. 

Ivanovic M.  Using Core Biopsy In Conjunction With Fine Needle Aspiration Decreases The unsatisfactory Rate.  United States and Canadian Academy of Pathology.  2007. 

Ivanovic M.  Using EUS-FNA in the Evaluation of Pancreatic Cystic Lesions: Five Years Experience from Northwestern University, Feinberg School of Medicine.  55th Annual Scientific Meeting of American Society of Cytopathology,.  2007. 

Ivanovic M.  Using EUS_FNA to Evaluate Gastrointestinal Submucosal Lesions: Application of Immunohistochemical Staining on Cell Block and Core Biopsy.  55th Annual Scientific Meeting of American Society of Cytopathology.  2007. 

Ivanovic M.  Absence of The T-Zone Component in the 22 Fields of View on the Thin Prep Imaging System: Is Re-screening Useful?.  American Society of Cytopathology 54th Annual Scientific Meeting.  2006. 

Ivanovic M.  Evaluation Of The Effectiveness Of Sending Atrophic Cervical Cytology Slides To QC For Detection Of Transformation Zone Component.  American Society of Cytopathology 54th Annual Scientific Meeting.  2006. 

Ivanovic M.  The Indeterminate Thyroid FNA:Sub-classification Improves Outcomes.  American Society of Cytopathology 54th Annual Scientific Meeting,.  2006. 

Ivanovic M.  Validation of The Thin Prep Imaging system (TIS) for Anal-Rectal Cytology (ARC) Preparation.  American Society of Cytopathology 54th Annual Scientific Meeting.  2006. 

Ivanovic M.  Immunohistochemical Profiles as an Aid in Borderline Prostatic Lesions.  19th European Congress of Pathology.  2003. 

Ivanovic M.  Comparison of Rates of Abnormalities in Cervico-Vaginal Pap Smears Between Different Countries.  Congress of Cervical Pathology and Colposcopy.  2002. 

Ivanovic M.  Predictive Value of Abnormal Pap Smears in Pre and Post-Menopausal Patients.  Proceedings of the XII International Congress of Cervical Pathology and Colposcopy.  2002. 

Ivanovic M.  The Use of Conventional Immunocytochemistry and HPV Detection to Distinguish Between Dysplasia and Atrophy in Liquid Cervicovaginal Samples.  Proceedings of the XII International Congress of Cervical Pathology and Colposcopy.  2002. 

Reiher F, Ivanovic M, Huang H, Smith N, Bouck N, Campbell S.  The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer.  The Journal of urology.  2001 June. 165(6 Pt 1):2075-81.
[PubMed]

Ivanovic M.  Control of the Growth of Human Bladder Cancer by a Thrombospondin-1 Mimetic.  Keystone Symposia.  2000 March. 

Ivanovic M.  Control of the Growth of Human Bladder Cancer by a Thrombospondin-1 Mimetic.  95th Annual Meeting of the American Urological Association.  2000. 

Ivanovic M.  Control of the Growth of Human Bladder Cancer by a Thrombospondin-1 Mimetic.  Journal of Urology.  2000. 163:120.

Ivanovic M.  Regulation of Angiogenesis in Bladder Cancer: Role of p53.  52nd Annual Meeting of the German Urological Association.  2000. 

Ivanovic M.  Regulation of Angiogenesis in Bladder Cancer: Role of p53.  95th Annual Meeting of the American Urological Association.  2000. 

Ivanovic M.  Regulation of Angiogenesis in Bladder Cancer: Role of p53.  Journal of Urology.  2000. 163:128 supplement.

Ivanovic M.  Molecular Mediators of Angiogenesis in Renal Cell Carcinoma.  Journal of Urology.  1999. 161 Supplement:112.

Ivanovic M.  The Effect of p53 and Hypoxia on Angiogenesis in Bladder Cancer.  Journal of Urology.  1999. 161 Supplement(161):112.

Campbell S, Volpert O, Ivanovic M, Bouck N.  Molecular mediators of angiogenesis in bladder cancer.  Cancer research.  1998 March. 58(6):1298-304.
[PubMed]

Ivanovic M.  Molecular Regulation of Angiogenesis in Bladder Cancer.  The Journal of Urology.  1998. 159 Supplement:286.

Ivanovic M.  Molecular Regulation of Angiogenesis in Bladder Cancer.  AACR.  1998 January. 

Ivanovic M.  Distribution of Breech Presentation Incidence During III Trimester of Pregnancy and Parturition.  1993. 

Ivanovic M.  Cytology-Radiology Atlas. 

Ivanovic M.  Cytopathology and its Histopathologycal Bases, Kidney, Adrenal Gland. 

Ivanovic M.  Cytopathology for Oncologists. 

Date Last Modified: 06/07/2014 - 21:56:23